Fat Taste Sensory Study

NCT ID: NCT03540693

Last Updated: 2021-04-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

105 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-04-06

Study Completion Date

2023-07-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Fat is the most energy dense macronutrient and consuming fat has been positively correlated to obesity. Individuals afflicted with obesity crave fat more frequently, have a higher preference for fatty taste, and consume a higher quantity of fatty foods. People who have undergone Roux-en-Y Gastric Bypass (RYGB) or Sleeve Gastrectomy (SG) weight-loss surgeries dramatically decrease their fat preferences and consumption of fat, at least within the first year after surgery. These surgeries are very effective in helping people lose weight over the first couple of years; however, approximately 30% of those who undergo these surgeries start regaining weight after the second year mark. Why some people are able to keep the weight off long-term but others are unable to is unclear. In addition, it is well-known that fat can modify the flavor of foods and flavor plays a critical role in consumption, as well as in responses that gear up the body to consume the food. These are known as cephalic phase responses and include neural, physiological, and hormonal aspects. The main goals of the study are twofold: 1) To test the immediate effects of RYGB surgery, SG surgery, and laparoscopic gastric banding (LAGB) surgery (a weight loss control group) on fat preferences and sensory perception, and 2) to compare fat preferences and sensory perception between those who are able to achieve sustained weight loss 2-5 years after RYGB or SG surgery and those who either regained weight or did not lose the desired amount.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

For the first goal, the investigators will assess a longitudinal group of subjects both before RYGB surgery (n=15) SG surgery (n=15), and LAGB surgery (n=15), and then again after they lose \~16% of their body weight post-surgery in the fed and the fasted state. the investigators will also study the same variables in a cross-sectional design consisting of two groups: a weight success group (n=30) and a weight failure group (n=30) 2-5 years post RYGB or SG surgery. The weight success group will include subjects who lost ≥40% body weight by 2-5 years post-surgery and the weight failure group will include subjects who lost \<25% body weight by 2-5 years post-surgery. In addition, the investigators will also explore the extent to which fat preferences and sensory perception in these subjects are affected by flavor related genes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bariatric Surgery Candidate Bariatric Surgical Procedure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

RYGB-longitudinal

Longitudinal group of subjects studied before and after Roux-n-Y gastric bypass surgery

RYGB

Intervention Type PROCEDURE

RYGB-weight loss surgery

SG_longitudinal

Longitudinal group of subjects studied before and after sleeve gastrectomy surgery

SG

Intervention Type PROCEDURE

SG- weight loss surgery

LAGB_longitudinal

Longitudinal group of subjects studied before and after laparoscopic gastric banding surgery

LAGB

Intervention Type PROCEDURE

LAGB- weight loss surgery

Weight-loss success

Subjects who lost ≥40% body weight by 2-5 years post-surgery

RYGB

Intervention Type PROCEDURE

RYGB-weight loss surgery

SG

Intervention Type PROCEDURE

SG- weight loss surgery

Weight-loss failure

Subjects who lost \<25% body weight (or lost more but then regain weight so that now are at \<25%) by 2-5 years post-surgery

RYGB

Intervention Type PROCEDURE

RYGB-weight loss surgery

SG

Intervention Type PROCEDURE

SG- weight loss surgery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

RYGB

RYGB-weight loss surgery

Intervention Type PROCEDURE

SG

SG- weight loss surgery

Intervention Type PROCEDURE

LAGB

LAGB- weight loss surgery

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women and men, 18-64 years of age, all races
* Subjects must be scheduled to undergo Roux-en-Y Gastric Bypass surgery (RYGB), Sleeve Gastrectomy surgery (SG), or laparoscopic gastric banding surgery (LAGB) and be available to be tested both pre- and post-surgery or must have undergone RYGB or SG surgery between 2-5 (i.e. at least two years ago and not more than 5) years ago and have a current weight loss that is ≥40% of body weight pre-surgery or \<25% of body weight pre-surgery.

Exclusion Criteria

* Smoking tobacco related cigarettes or having quit smoking less than 6 months ago
* Pregnant or breastfeeding
* Are experiencing significant organ dysfunction
* Take medications that could influence research results
* Have any psychiatric illness or disorder that could influence compliance or completion of the study
* History of chronic rhinitis
* Had a diagnosis of or are taking medicine to treat diabetes
* Inflammatory intestinal disease
* Subjects who underwent RYGB or SG between 2-3 years ago and have a current weight loss that is \<40% and ≥25% of their body weight pre-surgery.
* Subjects must find the taste of the food to be sham-fed acceptable (e.g. cream cheese, etc.).
Minimum Eligible Age

18 Years

Maximum Eligible Age

64 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Carle Foundation Hospital

OTHER

Sponsor Role collaborator

University of Illinois at Urbana-Champaign

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Marta Yanina Pepino de Gruev

Assisstant Professor of Ingestive Behavior

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Illinois at Urbana Champaign

Urbana, Illinois, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Belen R Acevedo, PhD

Role: primary

217-300-4709

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

18439

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.